Acadia Healthcare Company, Inc. $ACHC Stake Lifted by Envestnet Portfolio Solutions Inc.

Envestnet Portfolio Solutions Inc. increased its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 256.4% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 26,053 shares of the company’s stock after buying an additional 18,742 shares during the quarter. Envestnet Portfolio Solutions Inc.’s holdings in Acadia Healthcare were worth $591,000 at the end of the most recent quarter.

Other institutional investors have also recently added to or reduced their stakes in the company. GAMMA Investing LLC grew its stake in shares of Acadia Healthcare by 143.8% in the first quarter. GAMMA Investing LLC now owns 5,812 shares of the company’s stock worth $176,000 after purchasing an additional 3,428 shares in the last quarter. Caxton Associates LLP bought a new position in shares of Acadia Healthcare in the first quarter worth $394,000. PNC Financial Services Group Inc. grew its stake in shares of Acadia Healthcare by 10.3% in the first quarter. PNC Financial Services Group Inc. now owns 6,672 shares of the company’s stock worth $202,000 after purchasing an additional 622 shares in the last quarter. Janney Montgomery Scott LLC bought a new position in shares of Acadia Healthcare in the second quarter worth $479,000. Finally, Raiffeisen Bank International AG grew its stake in shares of Acadia Healthcare by 33.3% in the first quarter. Raiffeisen Bank International AG now owns 160,000 shares of the company’s stock worth $4,819,000 after purchasing an additional 40,000 shares in the last quarter.

Analyst Ratings Changes

Several research analysts have recently issued reports on ACHC shares. Bank of America cut Acadia Healthcare from a “buy” rating to a “neutral” rating and decreased their price target for the stock from $27.00 to $25.00 in a research note on Wednesday, September 10th. Weiss Ratings reissued a “sell (d)” rating on shares of Acadia Healthcare in a research note on Wednesday, October 8th. Mizuho decreased their price target on Acadia Healthcare from $32.00 to $22.00 and set a “neutral” rating for the company in a research note on Wednesday, August 13th. UBS Group cut their price objective on Acadia Healthcare from $45.00 to $31.00 and set a “buy” rating for the company in a report on Thursday, August 7th. Finally, Cowen restated a “buy” rating on shares of Acadia Healthcare in a report on Thursday, August 7th. Eight analysts have rated the stock with a Buy rating, five have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat.com, Acadia Healthcare has a consensus rating of “Moderate Buy” and a consensus target price of $35.09.

Acadia Healthcare Trading Down 1.9%

Shares of NASDAQ ACHC opened at $23.51 on Wednesday. Acadia Healthcare Company, Inc. has a 12 month low of $17.13 and a 12 month high of $53.08. The company has a market cap of $2.17 billion, a price-to-earnings ratio of 15.57, a P/E/G ratio of 4.75 and a beta of 0.90. The company has a quick ratio of 1.32, a current ratio of 1.32 and a debt-to-equity ratio of 0.73. The business has a fifty day simple moving average of $23.27 and a 200-day simple moving average of $23.13.

Acadia Healthcare (NASDAQ:ACHC) last announced its earnings results on Tuesday, August 5th. The company reported $0.83 EPS for the quarter, beating the consensus estimate of $0.71 by $0.12. Acadia Healthcare had a return on equity of 8.34% and a net margin of 4.31%.The business had revenue of $869.23 million during the quarter, compared to the consensus estimate of $839.59 million. During the same period in the prior year, the business posted $0.91 earnings per share. Acadia Healthcare’s revenue was up 9.2% compared to the same quarter last year. Acadia Healthcare has set its FY 2025 guidance at 2.450-2.65 EPS. Sell-side analysts predict that Acadia Healthcare Company, Inc. will post 3.38 EPS for the current year.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.